August 2022 - COI, STOMP/STAMP, BP deprescribing, amiodarone and bempedoic acid

DTB Podcast

English - July 25, 2022 04:33 - 32 minutes - 73.4 MB - ★★★★★ - 4 ratings
Science Health & Fitness Medicine dtb drug and therapeutics bulletin therapy medical evidence Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: July 2022 - an e-letter, estradiol, APPGs, inclisiran and nitrofurantoin

Next Episode: September 2022 - healthcare costs, gout, metformin and B12, more on COI and carbetocin

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the August 2022 issue of DTB. They discuss progress in reducing use of psychotropic medications in adults and children with a learning disability, autism or both (https://dtb.bmj.com/content/60/8/114). They also provide an overview of a study that assessed the effect of deprescribing antihypertensive medication in older people (https://dtb.bmj.com/content/60/8/118) and talk about a national safety alert relating to amiodarone (https://dtb.bmj.com/content/60/8/116). They end the podcast with a discussion on the evidence for the lipid-lowering drug bempedoic acid and its effect on reducing low-density lipoprotein-cholesterol and the lack of evidence on clinical outcomes (https://dtb.bmj.com/content/60/8/120).
The contact address for the DTB team is [email protected].

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.